A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Clinical trial NCT05444556 · COMPLETED
Trial details
- NCT number
- NCT05444556
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2022-11-02
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.